4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease

Clinical trial NCT01039701 · COMPLETED

Trial details

NCT number: NCT01039701
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild to Moderate Alzheimer's Disease

Start date: 2009-12-01
Primary completion: 2010-07-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.